Up a level |
Pushpakom, SP ORCID: 0000-0002-6682-4235
(2018)
Nilotinib-induced metabolic dysfunction: insights from a translational study using in vitro adipocyte models and patient cohorts.
Leukemia.
Thompson, A ORCID: 0000-0002-7087-9415, Owens, L ORCID: 0000-0001-7549-9350, Pushpakom, SP ORCID: 0000-0002-6682-4235, Faizal, M and Pirmohamed, M ORCID: 0000-0002-7534-7266
(2015)
Pharmacotherapy for alcohol dependence: A stratified approach.
PHARMACOLOGY & THERAPEUTICS, 153.
pp. 10-24.
Pushpakom, SP ORCID: 0000-0002-6682-4235, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Taylor, Claire, Foster, Terry ORCID: 0000-0001-7725-7902, Spowart, Cath, Garcia-Finana, M ORCID: 0000-0003-4939-0575, Kemp, GJ ORCID: 0000-0002-8324-9666, Jaki, Thomas, Khoo, SH ORCID: 0000-0002-2769-0967, Williamson, Paula ORCID: 0000-0001-9802-6636 et al (show 1 more authors)
(2020)
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy.
Clinical Infectious Diseases, 70 (10).
pp. 2062-2072.